Pubdate: Sat, 06 Mar 2004 Source: Joplin Globe, The (MO) Copyright: 2004 The Joplin Globe Contact: http://www.joplinglobe.com/ Details: http://www.mapinc.org/media/859 Author: Kelly Meares Referenced: http://www.mapinc.org/drugnews/v04.n355.a05.html BOGUS DECLINE The Globe editorial "Ecstasy use in decline" (Feb. 29) touts the reported decline in Ecstasy use as an important gain in the "War on Drugs." Sad to say, unless you are George Bush, we should expect some fact-checking before a policy position is proffered. The "yellowcake" report in question is the highly discredited Johns Hopkins study by Drs. Ricaurte and McCann, who are alleged to harbor a very loaded agenda. This study attributed a 20 percent mortality rate and profound brain damage. This made major headlines in the modern age of Science by Press Conference. It was seized upon to justify the RAVE act, which justifies police-state powers to combat this "Reefer Madness"-type menace. Somehow, it even made it into the normally reliable publication Science. Guess what. All bogus. They "mixed" up the drug samples and injected methamphetamine at extreme dosage levels. Real scientists were skeptical from the beginning. Why would the actual emergency room statistics and mortality be so low? For some truth on the subject, check out thegooddrugsguide.com, or thedea.com. Seth Jackson, a frequent contributor here, recently implored people to study both sides of issues instead of wallowing in self-reinforcing dogma. Great advice! I expect and revere the hatemongering and fact-twisting in the letters section. But your journalistic standards must be higher. Your resource in this case is biased and unreliable, and should not be trusted again. A mea culpa or a retraction is in order. Who knows, if you dig into the facts, you might obtain a more enlightened attitude about the so-called "War on Drugs." The real harm to society is done by the policy of imprisonment and punishment instead of treatment and root-cause resolution. Kelly Meares Carl Junction - --- MAP posted-by: Larry Seguin